1. Home
  2. CADL vs IFN Comparison

CADL vs IFN Comparison

Compare CADL & IFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$8.83

Market Cap

578.8M

Sector

Health Care

ML Signal

HOLD

Logo India Fund Inc. (The)

IFN

India Fund Inc. (The)

HOLD

Current Price

$10.84

Market Cap

540.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
IFN
Founded
1999
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
578.8M
540.6M
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
CADL
IFN
Price
$8.83
$10.84
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$19.00
N/A
AVG Volume (30 Days)
2.2M
148.1K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$10.84
52 Week High
$9.27
$16.60

Technical Indicators

Market Signals
Indicator
CADL
IFN
Relative Strength Index (RSI) 68.29 28.34
Support Level $4.80 $10.84
Resistance Level $9.27 $11.79
Average True Range (ATR) 0.60 0.19
MACD -0.04 -0.06
Stochastic Oscillator 75.28 4.55

Price Performance

Historical Comparison
CADL
IFN

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About IFN India Fund Inc. (The)

India Fund Inc is an asset management company. The fund's investment objective is long-term capital appreciation, which it seeks to achieve by investing in the equity securities of Indian companies. The company's portfolio is a non-diversified closed-end management investment company across various sectors such as financials, consumer staples, information technology, materials, healthcare, consumer discretionary, industrials, telecommunication services, utilities, and others. Geographically, all the business activity functions through the market of the United States.

Share on Social Networks: